Miklós Gyuranecz’s project, "Demonstrating the efficacy of a live, attenuated Mycoplasma gallisepticum vaccine candidate" was awarded funding under the HUN-REN Innovate 2026 Program. Thirty-eight applications were submitted to the HUN-REN Innovate 2026 Program call; 25 advanced to the professional presentation stage, and ultimately, 14 projects received funding. The project aims to contribute to the long-term practical application of research findings.